Table 2 Comparison of albumin and prealbumin in different stages of SAP patients in survival group and non-survival group.
Non-survival | Survival | P | ||
|---|---|---|---|---|
Average serum albumin concentration (g/L) | ||||
Stage 1 | n = 33 | n = 166 | ||
Number of detections | 3 (0) | 3 (1) | 0.603 | |
Value | 33.16 ± 5.61 | 35.71 ± 5.00 | 0.012 | |
Stage 2 | n = 31 | n = 166 | ||
Number of detections | 4 (0) | 3 (2) | < 0.001 | |
Value | 37.08 ± 6.13 | 40.78 ± 5.44 | 0.004 | |
Stage 3 | n = 29 | n = 166 | ||
Number of detections | 5 (4) | 2 (3) | < 0.001 | |
Value | 37.80 ± 6.72 | 43.02 ± 6.06 | < 0.001 | |
Stage 4 | n = 23 | n = 154 | ||
Number of detections | 8 (8) | 4 (3) | < 0.001 | |
Value | 35.21 ± 4.82 | 42.91 ± 5.95 | < 0.001 | |
Average serum prealbumin concentration (g/L) | ||||
Stage 1 | n = 33 | n = 166 | ||
Number of detections | 3 (2) | 2 (1) | 0.636 | |
Value | 113.97 ± 56.56 | 131.59 ± 49.38 | 0.066 | |
Stage 2 | n = 31 | n = 166 | ||
Number of detections | 4 (0) | 3 (2) | 0.002 | |
Value | 105.82 ± 39.41 | 125.44 ± 43.50 | 0.024 | |
Stage 3 | n = 29 | n = 166 | ||
Number of detections | 5 (4) | 2 (3) | < 0.001 | |
Value | 123.14 ± 42.45 | 197.79 ± 78.21 | < 0.001 | |
Stage 4 | n = 23 | n = 153 | ||
Number of detections | 8 (9) | 4 (2) | < 0.001 | |
Value | 132.06 ± 65.01 | 243.40 ± 77.78 | < 0.001 | |
